1. Home
  2. ESPR vs DSX Comparison

ESPR vs DSX Comparison

Compare ESPR & DSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • DSX
  • Stock Information
  • Founded
  • ESPR 2008
  • DSX 1999
  • Country
  • ESPR United States
  • DSX Greece
  • Employees
  • ESPR N/A
  • DSX N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • DSX Marine Transportation
  • Sector
  • ESPR Health Care
  • DSX Consumer Discretionary
  • Exchange
  • ESPR Nasdaq
  • DSX Nasdaq
  • Market Cap
  • ESPR 202.2M
  • DSX 172.5M
  • IPO Year
  • ESPR 2013
  • DSX 2005
  • Fundamental
  • Price
  • ESPR $1.20
  • DSX $1.62
  • Analyst Decision
  • ESPR Buy
  • DSX
  • Analyst Count
  • ESPR 6
  • DSX 0
  • Target Price
  • ESPR $6.50
  • DSX N/A
  • AVG Volume (30 Days)
  • ESPR 3.1M
  • DSX 274.6K
  • Earning Date
  • ESPR 08-11-2025
  • DSX 07-30-2025
  • Dividend Yield
  • ESPR N/A
  • DSX 2.47%
  • EPS Growth
  • ESPR N/A
  • DSX N/A
  • EPS
  • ESPR N/A
  • DSX 0.05
  • Revenue
  • ESPR $259,574,000.00
  • DSX $225,498,000.00
  • Revenue This Year
  • ESPR $4.07
  • DSX N/A
  • Revenue Next Year
  • ESPR N/A
  • DSX $12.09
  • P/E Ratio
  • ESPR N/A
  • DSX $29.93
  • Revenue Growth
  • ESPR 12.99
  • DSX N/A
  • 52 Week Low
  • ESPR $0.69
  • DSX $1.27
  • 52 Week High
  • ESPR $3.94
  • DSX $2.92
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 63.86
  • DSX 57.85
  • Support Level
  • ESPR $1.10
  • DSX $1.48
  • Resistance Level
  • ESPR $1.26
  • DSX $1.54
  • Average True Range (ATR)
  • ESPR 0.08
  • DSX 0.05
  • MACD
  • ESPR 0.02
  • DSX 0.00
  • Stochastic Oscillator
  • ESPR 93.55
  • DSX 88.89

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

Share on Social Networks: